Clinical Trials Logo
  1. Home
  2. Antiphospholipid Syndrome
  3. NCT00616317
  4. Details
NCT00616317 Clinical Trial

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Antiphospholipid Syndrome Clinical Trial

— APS  

Official title:
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00616317
Other study ID # 235519
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 2006
Est. completion date January 2040

Study information
Verified date June 2023
Source University of California, Davis
Contact Lavjay Butani
Phone (916) 734-8118
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date January 2040
Est. primary completion date January 2040
Accepts healthy volunteers No
Gender All
Age group 1 Minute to 18 Years
Eligibility Inclusion Criteria: - 18 years of age or younger at the onset of disease - Presence of Vascular Thrombosis - UC Davis patient - Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: - Infants born to mothers with APS - Infants with congenital thrombophilia

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States UC Davis Medical Center Sacramento California

Sponsors (2)
Lead Sponsor Collaborator
University of California, Davis Ministry of Higher Education, Science and Technology, Solvenia

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Long term survival 10 year
See also
  Status Clinical Trial Phase
Completed NCT01475149 - Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) N/A
Completed NCT00537290 - A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome Phase 2
Recruiting NCT00198068 - Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Completed NCT00180817 - Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Completed NCT03682419 - Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) N/A
Not yet recruiting NCT03303508 - Measurement of Anti-dsDNA by Both CLIFT & ELISA N/A
Recruiting NCT04262492 - International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Withdrawn NCT00180778 - Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss Phase 1/Phase 2
Enrolling by invitation NCT05583305 - Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
Recruiting NCT05644210 - Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Recruiting NCT02303171 - Use of Warfarin After the First Trimester in Pregnant Women With APS Phase 4
Not yet recruiting NCT06420154 - The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases Early Phase 1
Completed NCT00674297 - Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients Phase 2
Recruiting NCT05859997 - Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases N/A
Recruiting NCT06373003 - Negative Antiphospholipid Syndrome: a Multicentric Study
Recruiting NCT06373926 - Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome N/A
Recruiting NCT01818505 - The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome N/A
Completed NCT00878137 - Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin N/A
Completed NCT01104337 - Drug Interaction Between Paracetamol and Warfarin Phase 4
Completed NCT05313048 - Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

External Links